Deadline Extended to March 17, 2016!

**Please note that the online application portal will not be available from 12:00pm EST Friday March 11 through 9:00am EST
Monday March 14.

2016 ASPIRE Rheumatology, Dermatology and Inflammatory Bowel Disease Research Awards

This ASPIRE program is part of Pfizer's commitment to supporting research in autoimmune diseases within rheumatology, dermatology and inflammatory bowel disease.

Mission

The mission of the ASPIRE program is to fund high quality basic science, translational and clinical research through a competitive grants program that advances medical knowledge in the epidemiology, pathogenesis and treatment of selected diseases.

Background

Scientific research continues to advance our knowledge and understanding of autoimmune diseases within rheumatology, dermatology and inflammatory bowel disease. The 2016 ASPIRE Rheumatology, Dermatology and Inflammatory Bowel Disease Research Awards will fund meritorious research proposals that have the potential to improve patient care.

Areas of Focus

Research areas of interest in rheumatoid arthritis, dermatology and inflammatory bowel disease are as follows:

General Rheumatoid Arthritis Dermatology Inflammatory bowel disease

Available Awards

ASPIRE Rheumatology, Dermatology and Inflammatory Bowel Disease research awards are up to a maximum of $150,000 each. Research projects are expected to complete within 2 years of study start. Larger grants may be considered depending on scope and merit of proposal.